Display options
Share it on

Lupus Sci Med. 2019 Jul 31;6(1):e000333. doi: 10.1136/lupus-2019-000333. eCollection 2019.

Elevated serum complement levels and higher gene copy number of complement .

Lupus science & medicine

Evan Mulvihill, Stacy Ardoin, Susan D Thompson, Bi Zhou, Gakit Richard Yu, Emily King, Nora Singer, D M Levy, Hermine Brunner, Yee Ling Wu, Haikady N Nagaraja, Laura Eve Schanberg, Chack-Yung Yu

Affiliations

  1. Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, Ohio, USA.
  2. Division of Rheumatology, Nationwide Children's Hospitatl, Columbus, OH, USA.
  3. Department of Pediatrics, The Ohio State University, Columbus, Ohio, USA.
  4. Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital Medical Centre, Cincinnati, Ohio, USA.
  5. Center for Microbial Pathogenesis, Abigail Wexner Research Institute, Columbus, Ohio, USA.
  6. Department of Medicine, University Hospitals/Case Medical Center, Cleveland, Ohio, USA.
  7. Department of Rheumatology, Hospital for Sick Children and Univeristy of Toronto, Toronto, Ontario, Canada.
  8. Department of Pediatrics, University of Cincinnati, Cincinnati Children's Hospital Medical Center, PRCSG Coordinating Center, Cincinnati, Ohio, USA.
  9. Department of Medical Microbiology and Immunology, Loyola University Chicago, Chicago, Illinois, USA.
  10. Division of Biostatistics, College of Public Health, The Ohio State University, Columbus, Ohio, USA.
  11. Department of Pediatrics, Duke University, Durham, North Carolina, USA.
  12. Center for Microbial Pathogenesis, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, Ohio, USA.

PMID: 31448126 PMCID: PMC6687033 DOI: 10.1136/lupus-2019-000333

Abstract

OBJECTIVE: Systemic lupus erythematosus (SLE) features high frequency of cardiovascular disease (CVD) and fluctuating complement levels. The clinical trial Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) aimed to evaluate whether atorvastatin treatment reduced the progression of atherosclerosis in 221 patients with childhood-onset SLE (cSLE), using carotid intima media thickness (CIMT) as surrogates. We leveraged APPLE biorepository and trial data to investigate the relationship between

METHODS: Gene copy numbers (GCNs) for total

RESULTS: At baseline, C4 protein levels strongly correlated with GCNs of total

CONCLUSIONS: cSLE with hypertension had elevated serum levels of C4 and C3 and higher GCN of

Keywords: atherosclerosis; atorvastatin; complement C4 and C3; gene copy number variation; hypertension

Conflict of interest statement

Competing interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. Acta Cardiol. 1998;53(6):345-54 - PubMed
  2. J Biol Chem. 1999 Apr 23;274(17):12147-56 - PubMed
  3. Circulation. 1999 Jul 6;100(1):96-102 - PubMed
  4. Am J Hum Genet. 2002 Oct;71(4):810-22 - PubMed
  5. AMA Arch Derm Syphilol. 1953 Aug;68(2):119-28 - PubMed
  6. J Am Soc Nephrol. 2004 Feb;15(2):241-50 - PubMed
  7. J Immunol. 2004 Aug 15;173(4):2803-14 - PubMed
  8. Am J Clin Nutr. 2006 Feb;83(2):456S-460S - PubMed
  9. Kidney Int. 2007 Mar;71(6):491-5 - PubMed
  10. Am J Hum Genet. 2007 Jun;80(6):1037-54 - PubMed
  11. Eur J Cardiovasc Prev Rehabil. 2007 Jun;14(3):392-7 - PubMed
  12. J Immunol. 2007 Sep 1;179(5):3012-25 - PubMed
  13. Curr Protoc Immunol. 2005 Sep;Chapter 13:Unit 13.8 - PubMed
  14. J Exp Med. 1990 Oct 1;172(4):1011-7 - PubMed
  15. Rheum Dis Clin North Am. 2010 Feb;36(1):53-80, vii-viii - PubMed
  16. Lupus. 2010 Oct;19(11):1272-80 - PubMed
  17. Proc Natl Acad Sci U S A. 2011 May 24;108(21):8761-6 - PubMed
  18. Arthritis Rheum. 2012 Jan;64(1):285-96 - PubMed
  19. Arthritis Care Res (Hoboken). 2012 Dec;64(12):1787-93 - PubMed
  20. Ann Rheum Dis. 2014 Mar;73(3):557-66 - PubMed
  21. Diagn Pathol. 2013 Jun 13;8:93 - PubMed
  22. J Cardiovasc Pharmacol. 2013 Sep;62(3):255-62 - PubMed
  23. Circulation. 2014 Jun 24;129(25 Suppl 2):S76-99 - PubMed
  24. EMBO J. 1986 Nov;5(11):2873-81 - PubMed
  25. Clin Exp Immunol. 1989 Mar;75(3):329-35 - PubMed
  26. Clin Exp Immunol. 1989 Oct;78(1):49-53 - PubMed
  27. Lupus Sci Med. 2014 Apr 30;1(1):e000011 - PubMed
  28. Ann Rheum Dis. 2016 Sep;75(9):1599-606 - PubMed
  29. Rheumatology (Oxford). 2016 May;55(5):869-73 - PubMed
  30. Arthritis Rheumatol. 2016 Jun;68(6):1442-1453 - PubMed
  31. Front Immunol. 2016 Feb 15;7:36 - PubMed
  32. Front Immunol. 2016 Feb 24;7:55 - PubMed
  33. Curr Opin Rheumatol. 2016 Sep;28(5):468-76 - PubMed
  34. Kidney Dis (Basel). 2015 Sep;1(2):91-9 - PubMed
  35. Front Immunol. 2019 May 07;10:885 - PubMed
  36. EMBO J. 1984 Aug;3(8):1819-23 - PubMed
  37. J Immunol. 1984 Jun;132(6):3019-27 - PubMed
  38. Nephrol Dial Transplant. 1994;9(11):1564-7 - PubMed
  39. Circulation. 1997 Sep 2;96(5):1432-7 - PubMed
  40. Arthritis Rheum. 1997 Sep;40(9):1725 - PubMed
  41. Clin Exp Immunol. 1997 Nov;110(2):310-6 - PubMed

Publication Types

Grant support